BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 23137231)

  • 1. Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.
    Castelli R; Zanichelli A; Cugno M
    Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):181-90. PubMed ID: 23137231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation.
    Cugno M; Castelli R; Cicardi M
    Autoimmun Rev; 2008 Dec; 8(2):156-9. PubMed ID: 19014872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress.
    Cugno M; Zanichelli A; Foieni F; Caccia S; Cicardi M
    Trends Mol Med; 2009 Feb; 15(2):69-78. PubMed ID: 19162547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic test indications and interpretations in patients with hereditary angioedema.
    Weiler CR; van Dellen RG
    Mayo Clin Proc; 2006 Jul; 81(7):958-72. PubMed ID: 16835976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity.
    Wu MA; Castelli R
    Clin Chem Lab Med; 2016 Feb; 54(2):207-14. PubMed ID: 26068904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
    Zeerleder S; Levi M
    Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
    Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
    Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First case of homozygous C1 inhibitor deficiency.
    Blanch A; Roche O; Urrutia I; Gamboa P; Fontán G; López-Trascasa M
    J Allergy Clin Immunol; 2006 Dec; 118(6):1330-5. PubMed ID: 17137866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
    Joseph K; Tholanikunnel TE; Kaplan AP
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonallergic angioedema: role of bradykinin.
    Bas M; Adams V; Suvorava T; Niehues T; Hoffmann TK; Kojda G
    Allergy; 2007 Aug; 62(8):842-56. PubMed ID: 17620062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship.
    Castelli R; Zanichelli A; Cicardi M; Cugno M
    Crit Rev Oncol Hematol; 2013 Sep; 87(3):323-32. PubMed ID: 23490322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency.
    Zanichelli A; Mansi M; Periti G; Cicardi M
    Expert Rev Clin Immunol; 2013 May; 9(5):477-88. PubMed ID: 23634741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evidence based therapeutic approach to hereditary and acquired angioedema.
    Bork K
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
    Craig TJ; Bernstein JA; Farkas H; Bouillet L; Boccon-Gibod I
    Int Arch Allergy Immunol; 2014; 165(2):119-27. PubMed ID: 25401373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of hereditary angioedema.
    Canonica GW; Rossi O
    Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema.
    Andrási N; Veszeli N; Kőhalmi KV; Csuka D; Temesszentandrási G; Varga L; Farkas H
    J Allergy Clin Immunol Pract; 2018; 6(4):1205-1208. PubMed ID: 29715562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
    Jacobs J; Neeno T
    Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
    Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
    J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary angioedema: Historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis.
    Khan DA
    Allergy Asthma Proc; 2011; 32(1):1-10. PubMed ID: 21262092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.